menu
    • menu

    Company profile for Arrowhead Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, th...
    Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arrowhead PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    225 South Lake Avenue, Suite 1050 Pasadena, CA 91101
    Telephone
    Telephone
    626-304-3400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://arrowheadpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arrowhead Pharma To Join December 2025 Conferences
    Arrowhead Pharma To Join December 2025 Conferences

    01 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251201268006/en/Arrowhead-Pharmaceuticals-to-Participate-in-Upcoming-December-2025-Conferences

    BUSINESSWIRE
    01 Dec 2025
    Share Share
    Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results
    Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125389358/en/Arrowhead-Pharmaceuticals-Reports-2025-Fiscal-Year-End-Results

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    Arrowhead Pharma Receives $200M Milestone Payment From Sarepta
    Arrowhead Pharma Receives $200M Milestone Payment From Sarepta

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124338777/en/Arrowhead-Pharmaceuticals-Earns-%24200-Million-Milestone-Payment-from-Sarepta-Therapeutics

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    FDA Approves Arrowhead's Genetic Disorder Drug
    FDA Approves Arrowhead's Genetic Disorder Drug

    18 Nov 2025

    // FDA

    https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-reduce-triglycerides-adults-familial-chylomicronemia-syndrome

    FDA
    18 Nov 2025
    Share Share
    Arrowhead Pharma’s Redemplo Receives Approval in US
    Arrowhead Pharma’s Redemplo Receives Approval in US

    18 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219947

    FDA
    18 Nov 2025
    Share Share
    Arrowhead Pharmaceuticals To Webcast Fiscal 2025 Year-End Results
    Arrowhead Pharmaceuticals To Webcast Fiscal 2025 Year-End Results

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106948630/en/Arrowhead-Pharmaceuticals-to-Webcast-Fiscal-2025-Year-End-Results

    BUSINESSWIRE
    06 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search